# Biocompatibility Analysis of a Herbal Amalgamation Containing Nochi, Vilvam, and Adhimadhuram Ethanolic Extracts on Vero Cell Line

**Authors:** Shalini Govindaraj, Magesh Karuppur Thiagarajan, Swaathi Ravindran, Sathyakumar Mayilvakanam, Aravindhan Ravi, Sivachandran Annamalai

PMC · DOI: 10.7759/cureus.77680 · Cureus · 2025-01-19

## TL;DR

This study tested a herbal blend's safety on Vero cells and found it to be biocompatible with low toxicity.

## Contribution

The study introduces a novel herbal formulation and evaluates its biocompatibility on a cell line for potential biomedical use.

## Key findings

- The herbal formulation showed dose-dependent cytotoxicity on Vero cells.
- The blend exhibited high biocompatibility with negligible toxicity at lower concentrations.
- Cell viability was maintained, suggesting potential for future biomedical applications.

## Abstract

Objective

This study aimed to examine the biocompatibility and potential synergistic therapeutic effects of a blend of ethanolic extracts derived from the medicinal herbs Vilvam, Nochi, and Adhimadhuram on the Vero cell line.

Materials and methods

The Vero cell line was obtained from the National Centre for Cell Sciences (NCCS), Pune. A herbal formulation was prepared by blending Nochi, Vilvam, and Adhimadhuram ethanolic extracts. The Vero cell line was then evaluated for the effects of the herbal amalgamation at concentrations of 1000 µg, 500 µg, 250 µg, 125 µg, 62.5 µg, 31.2 µg, 15.6 µg, and 7.8 µg with assessments conducted at 24-h and 48-h time points. Untreated cells served as the control.

Results

The herbal elixir exhibited heightened cytotoxicity on the Vero cells, leading to a corresponding decline in the viable cell percentage as the concentration of the formulation was increased. To evaluate the biocompatibility of the herbal consortium on the Vero cell line, a 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay was carried out over a 24-48-h period of incubation with seven different concentrations as follows: 500 µg, 250 µg, 125 µg, 62.5 µg, 31.2 µg, 15.6 µg, and 7.8 µg. A dose-dependent cell viability was observed. Every experiment was conducted three times.

Conclusion

The herbal formulation showcases impressive biocompatibility. The promising initial results from Vero cell testing represent the first step in a potentially lengthy journey toward clinical application. Vero cell testing demonstrated the herbal blend's exceptional capacity to support cell viability with negligible toxicity, strongly indicating its suitability for future biomedical applications. However, realizing the full potential of this promising herbal consortium will necessitate extensive further research, including rigorous animal studies and clinical trials to meticulously evaluate its safety and efficacy. A deeper investigation into the underlying biocompatibility mechanisms and therapeutic properties will be pivotal to unlocking the transformative possibilities of this innovative herbal blend. Given the burgeoning interest in natural and herbal remedies, this formulation holds tremendous promise; however, its full potential can only be realized through rigorous, systematic scientific evaluation.

## Full-text entities

- **Diseases:** cytotoxicity (MESH:D064420)
- **Chemicals:** Amalgamation (-), MTT (MESH:C070243), 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MESH:C022616)
- **Cell lines:** Vero — Chlorocebus sabaeus (Green monkey), Spontaneously immortalized cell line (CVCL_0059)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11835787/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11835787/full.md

## References

36 references — full list in the complete paper: https://tomesphere.com/paper/PMC11835787/full.md

---
Source: https://tomesphere.com/paper/PMC11835787